Search results
Showing 1396 to 1410 of 1597 results for nice quality standards or clinical guidelines
Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancer (TA707)
Evidence-based recommendations on Nivolumab (Opdivo) for previously treated unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma in adults.
NICE has developed a medtech innovation briefing (MIB) on EpiFix for chronic wounds .
Voclosporin with mycophenolate mofetil for treating lupus nephritis (TA882)
Evidence-based recommendations on voclosporin (Lupkynis) with mycophenolate mofetil for treating lupus nephritis in adults.
Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndrome (TA615)
Evidence-based recommendations on cannabidiol (Epidyolex) with clobazam for seizures associated with Lennox–Gastaut syndrome in people aged 2 years and older.
with regular patient/carer remote contact, ongoing assessment, monitoring, clinical decision making and person-centred care planning. In...
Xpert GBS test for the intrapartum detection of group B streptococcus (MIB28)
NICE has developed a medtech innovation briefing (MIB) on Xpert GBS test for the intrapartum detection of group B streptococcus
and optimise their function before, during and after treatment. The NICE guidelines – Improving outcomes in head and neck...
Improved identification of familial hypercholesterolaemia (FH) in primary care
Shared learning database Organisation: Medway Clinical Commissioning Group Published date: March 2015
Evidence summaries: new medicines – Interim process statement (PMG1)
Evidence summaries: new medicines – Interim process statement
Guide to the methods of technology appraisal 2013
Sexual Health in Practice Training to increase HIV testing in primary care
interest company is an implementation partner that supports delivery of high quality and effective sexual and reproductive health care...
Introducing therapy champions to improve the 24 hour approach to patient rehabilitation
working HCA shifts. The work supports delivery of several NICE guidelines and quality standards,...
Evidence-based recommendations on aflibercept (Zaltrap) with irinotecan and fluorouracil-based therapy (FOLFIRI) for treating metastatic colorectal cancer after oxaliplatin-based chemotherapy in adults.
Evidence-based recommendations on certolizumab pegol (Cimzia) and secukinumab (Cosentyx) for treating active psoriatic arthritis in adults.
Ustekinumab for the treatment of adults with moderate to severe psoriasis (TA180)
Evidence-based recommendations on ustekinumab (Stelara) for treating psoriasis in adults.